Eisai
4523.T
#2013
Rank
NZ$13.90 B
Marketcap
$49.33
Share price
0.12%
Change (1 day)
-38.62%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : NZ$1.83 Billion

According to Eisai's latest financial reports the company's total debt is NZ$1.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-03-31NZ$1.50 B35.35%
2022-03-31NZ$1.11 B-4.28%
2021-03-31NZ$1.16 B-15.86%
2020-03-31NZ$1.38 B-24.7%
2019-03-31NZ$1.83 B-18.21%
2018-03-31NZ$2.24 B-17.51%
2017-03-31NZ$2.72 B3.9%
2016-03-31NZ$2.62 B0.09%
2015-03-31NZ$2.62 B-5.39%
2014-03-31NZ$2.77 B-30.33%
2013-03-31NZ$3.97 B-21.63%
2012-03-31NZ$5.07 B-15.33%
2011-03-31NZ$5.99 B-3.28%
2010-03-31NZ$6.19 B-18.51%
2009-03-31NZ$7.60 B44.06%
2008-03-31NZ$5.27 B188411.01%
2007-03-31NZ$2.8 M-50.97%
2006-03-31NZ$5.71 M-47.71%
2005-03-31NZ$10.92 M297.41%
2004-03-31NZ$2.74 M413.23%
2003-03-31NZ$0.53 M-99.52%
2002-03-31NZ$0.11 B-29.32%
2001-03-31NZ$0.15 B-55.64%
2000-03-31NZ$0.35 B